Skip to search boxSkip to navigationSkip to main content

The selection of summary measures for ART outcome data - 'Reveal codes'

  • P. G. McDonough
  • Unknown
Scholary Output:
Contribution to journal
Letter
Peer-review

Open access

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 870-872 (3 pages)

Journal (Volume, Issue Number)

Fertility and sterility (Volume 73, Issue 4)

Publication milestones

  • Published - 2000

Publication status

Published - 2000

ISSN

0015-0282

Publication IDs

  • Scopus: 0034017922
  • PubMed: 10787291

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
1.43
SciVal
Author count
1
SciVal
citations
1
SciVal
Paper percentile
30
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
11
Citation count
1

Funding Details

The topic of multiple pregnancy as a complication of ovarian stimulation was discussed at a meeting in Washington on November 19, 1999. The meeting was sponsored by the National Institutes of Health and the newly established Bertarelli Foundation. The latter is a newly established foundation, based in Switzerland, that aims to promote and improve the understanding of the many dimensions of reproductive health. The board of directors reads like a who’s who in the reproductive sciences. Apparently, summary measures for ART occupied a significant portion of that meeting. One of the prime movers for locating the initial meeting on this specific topic in the United States is someone who firmly believes that individuals can make a difference—Eli Adashi. Doctor Adashi is the conscience of us all. He feels that the United States should lead the way in these matters and is determined to change human nature for the better. He knows that improving the technology will be for naught if human nature stays the same. Show biz is about illusion, but ART doesn’t have to be.
FundersFunding numbers
NIH
-
FB
-